Skip to Content

Empower Core Strategies Intl Eq Inv MXEVX

Medalist Rating as of | See Empower Investment Hub
  • NAV / 1-Day Return 10.42  /  +0.97 %
  • Total Assets 765.2 Mil
  • Adj. Expense Ratio
    1.000%
  • Expense Ratio 1.000%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.86%
  • Turnover 16%

USD | NAV as of May 04, 2024 | 1-Day Return as of May 04, 2024, 12:13 AM GMT+0

Morningstar’s Analysis MXEVX

Will MXEVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Empower Core Strategies Intl Eq Inv earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MXEVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 10.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novartis AG Registered Shares

1.52 8.8 Mil
Healthcare

ASML Holding NV

1.35 7.8 Mil
Technology

Shell PLC

1.24 7.2 Mil
Energy

Novo Nordisk A/S Class B

1.04 6.0 Mil
Healthcare

Roche Holding AG

0.99 5.7 Mil
Healthcare

Nestle SA

0.95 5.5 Mil
Consumer Defensive

TotalEnergies SE

0.94 5.5 Mil
Energy

HSBC Holdings PLC

0.84 4.8 Mil
Financial Services

Sanofi SA

0.81 4.7 Mil
Healthcare

Alcon Inc

0.80 4.6 Mil
Healthcare